Tirofiban after stent treatment for burst brain aneurysm
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a medicine called tirofiban that helps prevent blood clots after a stent is placed to treat a burst brain aneurysm. The goal is to see if adding this medicine improves recovery and reduces the chance of another bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You had bleeding in the brain (confirmed by a scan) from a burst brain aneurysm.
- You had a stent (a mesh tube) placed to treat the aneurysm.
- The treatment was done within 72 hours of the bleeding starting.
- You do not have a blood-clotting problem or a very low platelet count.
- You are not pregnant, breastfeeding, or recently gave birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug ticagrelor, which helps prevent blood clots, can reduce the risk of a stroke occurring days after a mild form of bleeding in the brain. It is given as an add-on to the standard treatment for the bleeding aneurysm.
This study tests a blood-thinning medicine called tirofiban to see if it helps reduce delayed brain damage after a type of stroke from a bleeding brain aneurysm. It is for people who have already had their aneurysm fixed with coiling, and the medicine is given soon after.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
This trial tests a medication called tirofiban, which helps prevent blood clots, given after a successful procedure to remove a clot from a large brain artery. The goal is to see if it can reduce disability after a stroke when given within 24 hours of symptom onset.
This trial tests whether adding a medicine called tirofiban (which helps prevent blood clots) after standard stroke treatment can improve recovery in people who had a stroke due to a blocked large artery in the brain. It is for people who already received a clot-busting drug and a mechanical clot removal procedure, and who have not fully recovered.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
Hear when a new Ruptured Intracranial Aneurysms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.